Frontiers | The Lung, the Heart, the Novel Coronavirus, and the Renin- Angiotensin System; The Need for Clinical Trials
ACE Inhibitors | SpringerLink
Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system? | Hypertension Research
Frontiers | Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer's disease, sarcopenia, cancer, and COVID-19
Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review | European Respiratory Society
Angiotensin and the Coronavirus | Science | AAAS
RAS-Hemmer (Renin-Angiotensin-System-Hemmstoffe) | Gelbe Liste
Angiotensinkonvertierendes Enzym 2 (ACE2): Rolle in der Pathogenese von Erkrankungen außerhalb von COVID-19 | Die Nephrologie
Frontiers | Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
JCM | Free Full-Text | Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
Kritischer Blick auf ACE-Hemmer
ACE2, a new regulator of the renin–angiotensin system: Trends in Endocrinology & Metabolism